Mellor AL - Search Results

1

Dendritic cells, indoleamine 2,3 dioxygenase and acquired immune privilege.

Huang L, Baban B, Johnson BA 3rd, Mellor AL. Huang L, et al. Among authors: mellor al. Int Rev Immunol. 2010 Apr;29(2):133-55. doi: 10.3109/08830180903349669. Int Rev Immunol. 2010. PMID: 20367139 Free PMC article. Review.

2

Prevention of allogeneic fetal rejection by tryptophan catabolism.

Munn DH, Zhou M, Attwood JT, Bondarev I, Conway SJ, Marshall B, Brown C, Mellor AL. Munn DH, et al. Among authors: mellor al. Science. 1998 Aug 21;281(5380):1191-3. doi: 10.1126/science.281.5380.1191. Science. 1998. PMID: 9712583

3

Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation?

Mellor AL, Munn DH. Mellor AL, et al. Immunol Today. 1999 Oct;20(10):469-73. doi: 10.1016/s0167-5699(99)01520-0. Immunol Today. 1999. PMID: 10500295 Review.

4

Prevention of T cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy.

Mellor AL, Sivakumar J, Chandler P, Smith K, Molina H, Mao D, Munn DH. Mellor AL, et al. Nat Immunol. 2001 Jan;2(1):64-8. doi: 10.1038/83183. Nat Immunol. 2001. PMID: 11135580

5

Maturation of antigen-presenting cells is compromised in HLA-G transgenic mice.

Horuzsko A, Lenfant F, Munn DH, Mellor AL. Horuzsko A, et al. Among authors: mellor al. Int Immunol. 2001 Mar;13(3):385-94. doi: 10.1093/intimm/13.3.385. Int Immunol. 2001. PMID: 11222508

6

Extinguishing maternal immune responses during pregnancy: implications for immunosuppression.

Mellor AL, Munn DH. Mellor AL, et al. Semin Immunol. 2001 Aug;13(4):213-8. doi: 10.1006/smim.2000.0317. Semin Immunol. 2001. PMID: 11437628 Review.

7

Tryptophan catabolism prevents maternal T cells from activating lethal anti-fetal immune responses.

Mellor AL, Munn DH. Mellor AL, et al. J Reprod Immunol. 2001 Oct-Nov;52(1-2):5-13. doi: 10.1016/s0165-0378(01)00118-8. J Reprod Immunol. 2001. PMID: 11600174 Review.

8

Functional expression of indoleamine 2,3-dioxygenase by murine CD8 alpha(+) dendritic cells.

Fallarino F, Vacca C, Orabona C, Belladonna ML, Bianchi R, Marshall B, Keskin DB, Mellor AL, Fioretti MC, Grohmann U, Puccetti P. Fallarino F, et al. Among authors: mellor al. Int Immunol. 2002 Jan;14(1):65-8. doi: 10.1093/intimm/14.1.65. Int Immunol. 2002. PMID: 11751753

9

Cells expressing indoleamine 2,3-dioxygenase inhibit T cell responses.

Mellor AL, Keskin DB, Johnson T, Chandler P, Munn DH. Mellor AL, et al. J Immunol. 2002 Apr 15;168(8):3771-6. doi: 10.4049/jimmunol.168.8.3771. J Immunol. 2002. PMID: 11937528

10

Indoleamine 2,3-dioxygenase contributes to tumor cell evasion of T cell-mediated rejection.

Friberg M, Jennings R, Alsarraj M, Dessureault S, Cantor A, Extermann M, Mellor AL, Munn DH, Antonia SJ. Friberg M, et al. Among authors: mellor al. Int J Cancer. 2002 Sep 10;101(2):151-5. doi: 10.1002/ijc.10645. Int J Cancer. 2002. PMID: 12209992

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

222 results

Search Page

Filters